During DCM progression, both hyperlipidemia and hyperglycemia could induce overproduction of ROS that further promote the oligomerization of NLRP3 as well as inflammatory programmed cell death [75]. The gene discussed is NLRP3; the disease is familial dilated cardiomyopathy.